1. Introduction {#sec1}
===============

Dendriform pulmonary ossification (DPO) is a rare lung disease characterized by the presence of mature bone in the lung parenchyma with typical radiologic findings of diffuse and numerous calcified nodules. Its pathophysiology is not well understood and treatment options are limited. Although it is commonly described in association with inflammatory conditions or fibrosis such as pathologic usual interstitial pneumonia (UIP), we present two cases of idiopathic DPO complicated by recurrent spontaneous pneumothoraces.

2. Case presentation {#sec2}
====================

2.1. Case 1 {#sec2.1}
-----------

A 53-year-old Caucasian male without underlying cardiopulmonary disease presented to a local emergency room with a one-day history of severe right-sided back and chest pain. The patient was a minimal smoker of only five pack years having quit 30 years prior to presentation. He denied recent infection, trauma, or specific environmental and occupational exposures. On physical examination, vital signs were normal and respiratory auscultation revealed diminished breath sounds on the right compared to the left without wheeze or crackles. Cardiovascular exam was unremarkable. Chest x-ray revealed a moderate-sized right pneumothorax. Computed tomography (CT) of the chest revealed bilateral partially calcified branching reticulonodular opacities with a basal predominance ([Fig. 1](#fig1){ref-type="fig"}). Mild architectural distortion was noted without traction bronchiectasis, reticulation, or honeycombing. Findings were consistent with likely dendriform pulmonary ossification. The patient was admitted for tube thoracostomy and subsequent video-assisted thoracoscopy (VATS) procedure with subtotal pleurectomy given prolonged air leak and difficulty with clearance. Biopsy results obtained during VATS revealed patchy foci of fibrous organizing pneumonia with multifocal ossifications. Post-procedure pulmonary function testing exhibited mild air trapping with a residual volume at 131% of predicted and isolated low diffusion capacity of 74%. Recurrent pneumothorax on the same side occurred eight months later with a similar presentation of acute dyspnea and chest discomfort. The patient underwent directed talc pleurodesis. After a normal recovery, no additional treatment was pursued with a recommended one-year follow-up chest CT and pulmonary function testing.Fig. 1(legend) Chest CT showing moderate sized right pneumothorax and bilateral partially calcified branching reticulonodular opacities with a mild basal predominance. Mild architectural distortion was noted without traction bronchiectasis or fibrosis.Fig. 1

2.2. Case 2 {#sec2.2}
-----------

A 45-year-old never-smoker Caucasian male presented for a second opinion regarding recurrent pneumothoraces. He had three prior left spontaneous pneumothoraces, the first being in 2011 that required chest tube drainage with two subsequent recurrences in 2017 and 2018 treated with mechanical and talc pleurodesis, respectively. Other medical history included childhood asthma with recurrence of symptoms around age 35 well controlled at the time of presentation with budesonide-formoterol, albuterol, and omalizumab. He was retired from the Navy and endorsed exposure to tear gas and beryllium. On presentation he was asymptomatic with normal vital signs. Respiratory auscultation revealed clear breath sounds bilaterally. Cardiovascular exam was unremarkable. Moderate obstruction (FEV1 2.23L, 55% of predicted; FEV1/FVC 0.60) with positive bronchodilator response was observed on pulmonary function testing. Lung volumes, diffusing capacity, and oximetry at rest and with exercise were normal. Chest CT revealed postoperative changes with multiple foci of high attenuation peripheral branching opacities greatest in the left lower lobe and several small non-calcified pulmonary nodules unchanged in comparison to previous imaging ([Fig. 2](#fig2){ref-type="fig"}). Review of prior biopsies suggested DPO with findings of cicatrical organizing pneumonia and associated extensive intra-alveolar ossification ([Fig. 3](#fig3){ref-type="fig"}). As the patient was stable and asymptomatic after pleurodesis, it was recommended he repeat a chest CT in approximately one year.Fig. 2(legend) Chest CT showing multiple foci of high attenuation peripheral branching opacities throughout the left lung, particularly in the left base. No evidence of fibrosis or bronchiectasis.Fig. 2Fig. 3(legend) Section showing fibrotic organizing pneumonia undergoing collagen deposition as well as prominent intraalveolar ossification with branching, dendritic, mature bone formation.Fig. 3

3. Discussion and conclusions {#sec3}
=============================

DPO is the less common of the two histologic forms of pulmonary ossification, an osseous metaplasia disorder defined by heterotopic mature bone formation (calcification in a collagen matrix) in the lung parenchyma \[[@bib1], [@bib2], [@bib3]\]. While nodular pulmonary ossification (NPO) is characterized by lobulated bone nodules within alveolar spaces in the absence of fat or marrow elements \[[@bib4]\], DPO is characterized by formation of branching bone tissue with marrow elements preferentially affecting the alveolar interstitium and extending through the alveolar septae \[[@bib2]\]. Overlap of the two patterns can be found in the same patient \[[@bib2],[@bib5]\]. DPO is often associated with underlying fibrotic lung disease, chronic inflammation, or sequelae of acute respiratory distress syndrome but may also be idiopathic \[[@bib9],[@bib12]\]. Pulmonary ossification is considered rare in clinical practice and is often a postmortem diagnosis due to subtle or nonspecific radiologic findings and clinical features. Prevalence in the general population is unknown, but reported incidence at autopsy ranges from 0.16 to 0.5% \[[@bib2],[@bib3],[@bib6]\]. A recent study of 43 patients reported in the literature found a male to female ratio of 6:1 and a mean age at diagnosis of 64 years \[[@bib6]\].

There are several proposed hypotheses regarding the etiology of DPO, however, the precise pathogenesis remains uncertain. DPO can be idiopathic or secondary to preexisting conditions such as fibrosis, chronic obstructive pulmonary disease (COPD), adult respiratory distress syndrome, organizing pneumonia, rare earth pneumoconiosis, asbestosis, medication-induced lung injury, and heavy metal exposure \[[@bib2],[@bib7], [@bib8], [@bib9], [@bib10], [@bib11]\]. It is presumed that interactions between pulmonary fibroblasts and macrophages lead to DPO as mediated or induced by various factors including cell and tissue injury, cytokines, growth factors, free radicals, and enzymes \[[@bib12], [@bib13], [@bib14]\]. Abnormal environmental pH caused by anoxia may also facilitate ossification \[[@bib5],[@bib13]\]. The familial clustering of some reported cases may imply a genetic predisposition \[[@bib15],[@bib16]\].

The clinical manifestations of DPO are usually insidious and nonspecific. Patients are often asymptomatic or exhibit only mild chronic cough or dyspnea \[[@bib6]\]. DPO complicated by spontaneous pneumothorax is exceedingly rare with only a few previously reported cases \[[@bib1],[@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23]\]. The exact mechanism for pneumothorax in DPO remains unclear. One proposed mechanism is possible injury to the visceral pleura from exposed peripheral parenchymal ossifications as seen on thoracoscopy \[[@bib1]\].

With the addition of our two cases, we found several interesting clinical features of DPO-associated pneumothorax. Ten additional reported cases of DPO complicated by spontaneous pneumothorax \[[@bib1],[@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23]\] were found and reviewed ([Table 1](#tbl1){ref-type="table"}). All patients including ours were male with an average age of 46 ± 17 years (mean ± SD) at the time of diagnosis. While there is a predominance of males in DPO, by comparison, DPO patients are generally diagnosed in their 60s (64 ± 17) \[[@bib6]\]. There were no active smokers. Four had chronic lung disease and three had suspected occupational exposure. Asthma history or an obstructive ventilatory defect was found in three and four patients, respectively. This appears consistent with previous findings from an autopsy study noting four out of eight DPO patients also had a history of COPD \[[@bib2]\]. Notably, there were no cases of associated lung fibrosis or usual interstitial pneumonia (UIP) pattern in this group \[[@bib9],[@bib10]\]. Most cases had a favorable outcome, while only one patient experienced slow progression over 16 years leading to lung transplant \[[@bib23]\].Table 1(Title) Summary of reported cases of diffuse pulmonary ossification complicated by pneumothorax.Table 1Patient numberGenderAge (at diagnosis)Smoking historyMedical historyOccupational exposureFamily historyPFT patternCT pattern (UIP?)RecurrenceTreatmentPrognosisFirst authorYear1Male51UnknownNoneNoneUnknownNormalUnknownNoSurgery via thoracotomyStableEkholdt, P.F. \[[@bib17]\]19862Male42Former smokerAsthmaUnknownUnknownObstructive impairmentNon-UIPYesSurgery via thoracotomyStableIkeda, Y. \[[@bib18]\]19983Male29UnknownNoneNonePulmonary ossificationUnknownNon-UIPNoSurgery via VATSStableAzuma, A. \[[@bib18]\]20034Male33Non-smokerAsthmaUnknownUnknownUnknownNon-UIPNoSurgery via VATSStableKato, T. \[[@bib1]\]20125Male83Non-smokerHypertension; carotid and coronary angioplastiesSilicaUnknownUnknownNon-UIPNoSurgery via VATSStableJungmann, H. \[[@bib19]\]20136Male68Non-smokerHypertension; chronic bronchitisUnknownUnknownUnknownNon-UIPNoSurgery via VATSStableKonoglou, M. \[[@bib20]\]20137Male53UnknownNoneUnknownUnknownUnknownNon-UIPYesSurgery via thoracotomyStableAbe, J. \[[@bib21]\]20148Male26Non-smokerNoneNoneFather with similar chest CT findings in his 30sUnknownNon-UIPYesSurgery via VATSStableTsai, A.P. \[[@bib16]\]20179Male43Non-smokerAtopic dermatitisNoneNoneUnknownNon-UIPYesNoneStableEdahiro, R. \[[@bib22]\]201810Male30Former smokerHypertensionIndustrial wasteMother with pulmonary calcificationRestrictive impairmentNon-UIPNoTube thoracostomySlowly progressed, waiting for lung transplant at 46- years-oldMatsuo, H. \[[@bib23]\]201811Male53Former smokerNoneNoneNoneObstructive impairmentNon-UIPYesTalc pleurodesisStableCase 112Male45Non-smokerAsthmaCS gas and berylliumNoneObstructive impairmentNon-UIPYesTalc pleurodesisStableCase 2

No specific treatment for DPO has been identified. Therapeutic approaches reported in the literature are centered on symptom or complication management. Spontaneous pneumothorax in DPO tends to be resistant to conventional treatments. Fifty percent of cases had at least one recurrence; 83.3% of patients ultimately underwent pleurodesis, thoracoscopic surgery, or thoracotomy. Only one patient was stable without any kind of intervention and one was successfully treated with tube thoracostomy alone ([Table 1](#tbl1){ref-type="table"}). Although association with chronic lung disease has been reported, there is no data to suggest that DPO progression or risk of pneumothorax is limited by directed treatment of the underlying lung disorders. Individualized imaging and pulmonary function testing for follow-up is recommended. Lung transplant is reserved for severe and progressive cases which occur uncommonly \[[@bib23],[@bib24]\].

In conclusion, DPO is a rare disorder with insidious and nonspecific symptoms often diagnosed by imaging and pathologically confirmed on autopsy with a generally benign and slowly progressive course. Spontaneous pneumothorax is an uncommon but clinically significant complication with an apparent propensity (from our cases and a review of the published literature) for younger to middle-aged men demonstrating obstructive pulmonary function findings but not fibrotic or interstitial lung disease, recurring in at least half. DPO-associated pneumothorax has a generally indolent course with good prognosis, though pneumothorax tends to be refractory to initial conservative measures and often requires aggressive management with pleurodesis.
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